Treatment options for DLBCL
Recorded on August 26th, 2024 as part of the DLBCL Adult Group in the Educational Webinar Program by HealthTree with Dr. Tycel Phillips. The HealthTree Foundation brings information from the experts to the patients! Learn more at https://healthtree.org/ Donate to the HealthTree Foundation or learn more about additional blood cancer support we offer here: https://give.healthtree.org/campaign/... HealthTree Cure Hub helps you find your best treatment options and accelerate cure for blood cancers. Join today at https://www.healthtree.org/
▶︎
All About Tumor Lysis Syndrome in DLBCL
▶︎
DLBCL in 2023: Top Docs Discuss the LATEST in Diffuse Large B-Cell Lymphoma | Treatments & Research
▶︎
Treatment-Free Ways to Delay Progression | Boston RT Sept 16, 2023
▶︎
Deep dive in diffuse large B cell lymphoma: Webcast - Dr. Kuruvilla, Princess Margaret Cancer Centre
▶︎
Understanding MGUS, Its Progression Risks, and More
▶︎
Acute Lymphoblastic Leukemia (ALL) Treatment: Understanding the 3 Stages for Patients
▶︎
Chronic Cancer Tests: Chronic Lymphocytic Leukemia | The Patient Story
▶︎
Updated Version Available- All About Abecma (Idecabtagene Vicleucel) for Myeloma -
▶︎
Bispecific Antibodies for Diffuse large B-cell lymphoma with Lorenzo Falchi, MD
▶︎
Relapsed and Refractory Diffuse Large B-Cell Lymphoma
▶︎
CLHSS iMpact Seminar | Kerry Sheets | May 5, 2026
▶︎
ACA Changes and Medicaid Expansion: What Blood Cancer Patients Need to Know and How to Stay Prepared
▶︎
Navigating Cancer Immunotherapy: Exploring the World of mRNA Vaccines
▶︎
Doctors break down every stage of lymphoma | Cancer: Explained | Macmillan Cancer Support
▶︎
A Compelling New Lupus Discovery with Jaehyuk Choi, MD, PhD
▶︎
The Latest in DLBCL Treatments: What Clinical Trials are Available to Me?
▶︎
Learn more about THYROID RFA: Dr. Jules Aljammal - #80
▶︎
Immunotherapy vs Chemotherapy: What Cancer Patients NEED to Know w/ Dr. Jason Konner MD | EP 99
▶︎
CAR-T Breakthroughs in Multiple Myeloma: What’s Changing Patient Outcomes | Mark Schroeder, MD
▶︎